S 463 · 107th Congress 2001โ€“2003, ended

Global Access to AIDS Treatment Act of 2001

Latest action · Mar 6, 2001 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1903-1904)

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 6, 2001
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Global Access to AIDS Treatment Act of 2001 - Declares it is U.S. policy that the United States will not seek the revocation or revision of intellectual property or competition laws or policies that regulate pharmaceuticals or medical technologies used to treat HIV/AIDS in any foreign country undergoing an HIV/AIDS-related public health crisis (sub-Saharan Africa and any other country determined by the President to be going through such crisis) if such foreign country's laws or policies: (1) promote access to such pharmaceuticals or technologies for affected populations; and (2) provide intellectual property protection consistent with the Agreement on Trade-Related Aspects of Intellectual Property Rights of the Uruguay Round Agreements Act.

Urges the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to: (1) carry out HIV/AIDS activities in foreign countries that are undergoing an HIV/AIDS-related public health crisis; and (2) lead the international organization of the manufacture and distribution of pharmaceuticals or medical technologies for HIV/AIDS, and the global registration of such products.

Amends the Trade Act of 1974 to exempt, with respect to HIV/AIDS pharmaceuticals and medical technologies, any foreign country that is undergoing an HIV/AIDS-related public health crisis, and is implementing laws or policies that regulate pharmaceuticals or medical technologies used to treat HIV/AIDS, from certain provisions declaring that a foreign country may be determined to deny adequate and effective protection of intellectual property rights even though it may be in compliance with the Agreement. Declares that such country shall be construed to provide adequate and effective protection of intellectual property rights if its laws or policies promote access to such pharmaceuticals or technologies for their affected populations or within other countries undergoing an HIV/AIDS-related public health crisis. Directs the President to instruct the United States Trade Representative not to seek the revocation or revision of such laws or policies.

Provides for the development and implementation of: (1) simplified and adapted protocols for the delivery of HIV/AIDS treatments in the resource-poor settings of the developing world; (2) programs to strengthen and broaden health care systems infrastructure, and the capacity of health care systems in developing foreign countries to deliver HIV/AIDS pharmaceuticals; and (3) a database of HIV/AIDS pharmaceuticals.

Amends the Public Health Service Act to establish the Foreign HIV/AIDS Assistance Loan Repayment Program to encourage physicians and other specified health professionals to provide HIV/AIDS treatment and care in developing foreign countries. Authorizes the Secretary of Health and Human Services to pay or defer up to $5,000 for graduate education loans provided to an individual under such program for each year of the individual's obligated service in providing HIV/AIDS-related services in a developing foreign country.

Cosponsors 3

Members who signed on, in the order they did. Signatures ran from Mar 6, 2001 to Apr 4, 2001; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-WIRussell D. FeingoldOriginalMar 6, 2001
D-HIDaniel K. InouyeMar 27, 2001
D-NYCharles E. SchumerApr 4, 2001

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred Mar 6, 2001

Actions 3

Everything that happened, newest first.

  1. Mar 6, 2001Introduced in Senate
  2. Mar 6, 2001Sponsor introductory remarks on measure. (CR S1902)
  3. Mar 6, 2001Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1903-1904)

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S1902Text printed S1903Dianne Feinstein D-CA (text)Mar 6, 2001

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to provide for increased access to HIV/AIDS-related treatments and services in developing foreign countries.
Short Titles as Introduced
Global Access to AIDS Treatment Act of 2001

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 6, 2001Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.